mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
0.37 |
0.01 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.01 |